Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sawai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sawai's Japan sales performance.

Merck and Ridgeback fulfil US deal for molnupiravir

Merck and Ridgeback fulfil US deal for molnupiravir Alongside the most recent US agreement, Merck has entered into purchase and supply deals for molnupiravir in over 30 markets globally including Canada, Korea, Australia, Japan, Thailand and Ukraine.

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment The combination is approved in both the EU and Japan for specific patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results Presently, Dupixent is approved in Europe, the US, Japan and other countries worldwide for use in specific patients with moderate-to-severe atopic dermatitis, as well as certain patients with asthma

FDA rejects Takeda’s Eohilia after delays

FDA rejects Takeda’s Eohilia after delays Dupixent is already approved in the US, Europe, Japan and other countries for specific patient populations with atopic dermatitis and asthma.

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn Under the new deal, Novartis will make an upfront payment of $300m to obtain the development and commercialisation rights to ociperlimab in the US, EU, Japan, Canada, Mexico and several European

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Viseven

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...